Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · IEX Real-Time Price · USD
4.370
+0.060 (1.39%)
Jul 22, 2024, 11:37 AM EDT - Market open
Elicio Therapeutics Employees
Elicio Therapeutics had 32 employees as of December 31, 2023. The number of employees increased by 9 or 39.13% compared to the previous year.
Employees
32
Change (1Y)
9
Growth (1Y)
39.13%
Revenue / Employee
n/a
Profits / Employee
-$1,218,531
Market Cap
46.42M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 32 | 9 | 39.13% |
Dec 31, 2022 | 23 | 1 | 4.55% |
Dec 31, 2020 | 22 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Apyx Medical | 252 |
Vicarious Surgical | 131 |
Carisma Therapeutics | 107 |
NextCure | 82 |
Kezar Life Sciences | 58 |
Protara Therapeutics | 27 |
Lantern Pharma | 21 |
Marker Therapeutics | 8 |
ELTX News
- 24 days ago - Elicio Therapeutics Announces Proposed Public Offering - GlobeNewsWire
- 24 days ago - Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P - GlobeNewsWire
- 4 weeks ago - Elicio Therapeutics Reports Inducement Grants - GlobeNewsWire
- 2 months ago - Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting - GlobeNewsWire
- 2 months ago - Elicio Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 3 months ago - Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting - GlobeNewsWire
- 3 months ago - Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting - GlobeNewsWire
- 4 months ago - Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates - GlobeNewsWire